Frederick L. Ruberg - Publications

Susceptibility and screening approaches in systemic amyloidosis: expert perspectives from the International Society of Amyloidosis (ISA).

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: September 04, 2026

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

Journal: JAMA

Published: August 30, 2026

Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy.

Journal: JAMA

Published: August 28, 2026

Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study.

Journal: Future cardiology

Published: August 03, 2026

Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM.

Journal: European journal of heart failure

Published: June 15, 2026

Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

Journal: Circulation. Cardiovascular imaging

Published: May 27, 2026

Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Published: May 21, 2026

Quantitative single photon emission computed tomography/computed tomography of Tc-99m-pyrophosphate scans: metrics for short-term risk stratification in transthyretin cardiac amyloidosis.

Journal: Nuclear medicine communications

Published: May 18, 2026

Fully Automated versus Human Echocardiogram Interpretation in Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study.

Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Published: April 17, 2026

Cardiac amyloidosis: Disease overview and novel pathophysiologic insights.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Published: March 17, 2026

Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.

Journal: Blood advances

Published: February 20, 2026

Diagnostic Performance of the Mayo ATTR-CM Score in Diverse Populations: Comparison With the AMY Score.

Journal: JACC. Advances

Published: January 20, 2026